Form 4: Immuneering Corp Director Peter Feinberg Increases Stake in Company

Peter Feinberg, a director at Immuneering Corp, recently increased his holdings of Class A Common Stock through a series of purchases.

Summary

• On March 18, 2024, Peter Feinberg purchased 45,024 shares of Class A Common Stock at a weighted average price of $2.3067 per share.
• A further 4,976 shares were purchased on the same day at a weighted average price of $3.0549 per share.
• On March 19, 2024, Feinberg acquired an additional 25,000 shares at $2.56 per share.
• Following these transactions, Feinberg directly owns 86,766 shares of Class A Common Stock.
• Feinberg also indirectly owns 392,242 shares through PF Associates L.P., 476,615 shares through PEF LLC, and 115,441 shares through S4K Investments LLC.

Sentiment

Score: 7

Explanation: Insider buying is generally viewed positively, suggesting confidence in the company's future. However, the scale of the purchase is relatively small compared to the overall market cap.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored as an indicator of management's sentiment about the company's prospects, relative to the current stock price.

Stakeholder Impact

• The increased stake by a director could positively influence shareholder sentiment.

Key Dates